The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 844.00
Ask: 846.00
Change: 4.00 (0.48%)
Spread: 2.00 (0.237%)
Open: 845.00
High: 847.00
Low: 839.00
Prev. Close: 838.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Full Year Trading Update

1 Feb 2024 07:00

RNS Number : 6051B
JTC PLC
01 February 2024
 

1 February 2024

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Pre-close Full Year Trading Update

 

Excellent organic growth and record new business in 2023

 

 

JTC, the global professional services business, today issues the following trading update in advance of its full year results for the year ended 31 December 2023.

 

2023 was another very successful year for the Company and one that saw it complete its Galaxy era goal of doubling the business a full two years earlier than anticipated. Notable achievements in 2023 included the completion of the acquisition of South Dakota Trust Company ("SDTC") and accompanying equity placing to new and existing shareholders, the growth and contribution from Treasury and Tax Compliance services and the securing of increased debt facilities to support delivery of the Cosmos business plan.

 

The strong momentum in net organic revenue growth reported at the interim results in September 2023 continued to the year-end, remaining significantly above the medium-term guidance range of 8% - 10% and 2022 performance of 12%. This was driven by record new business wins of £30.8m, representing a 25.2% increase on the prior year figure of £24.6m, with particularly strong growth from existing clients.

 

The Group's underlying EBITDA for the full year will be in line with market expectations and as expected the EBITDA margin will be at the lower end of the guidance range of 33% - 38%, reflecting the Group's continued investment in driving organic growth. Cash conversion was strong and the Company will deliver in excess of 90% for the full year. Leverage will also be towards the lower end of the guidance range of 1.5x to 2.0x underlying EBITDA.

 

The Group's inorganic efforts were primarily focused on the acquisition of SDTC, which completed on 3 August 2023. This made JTC the leading independent provider of services to the US personal trust sector. Post acquisition trading for SDTC is in line with expectations and the integration is underway and going well. The Company will evaluate further greenfield expansion opportunities in the US in the PCS market, and more broadly continues to appraise a varied pipeline of attractive acquisition opportunities capable of delivering strong returns for the Group. Post period end, the final earnout payment in relation to the acquisition of SALI Fund Management, LLC and SALI GP Holdings, LLC (together "SALI") was paid in full from internally generated cash following the attainment of the financial targets set upon acquisition in November 2021. JTC is pleased with the performance of the SALI business and how it has integrated into the Group, with particularly strong cultural alignment, and it continues to provide highly predictable, long-term revenue streams with further growth opportunities.

 

Nigel Le Quesne, CEO of JTC PLC, said:

 

"In a little under six years since our IPO in March 2018, we have quadrupled the size of the Group by delivering the goals and strategies set out in our Odyssey and Galaxy era business plans, with the latest, Galaxy, being completed two years ahead of schedule. Whilst growth is important in our rapidly consolidating market it is vital that this growth does not come at the cost of diluting our unique culture. Growth must be sustainable and make our business better. Having made two strategically important acquisitions in the US in the last two years our immediate priority is to deliver on our plans for growth for both the ICS and PCS Divisions in the US. We will continue to supplement organic growth with accretive and value-enhancing M&A.

 

Our business combines excellent resilience with strong organic and inorganic growth and this was demonstrated in the year with outstanding net organic growth and the further development of our platform in the US market across both Divisions. We remain extremely ambitious for the Group and thank all of our employee owners for their strong contributions in 2023 and in particular the achievement of our Galaxy era plan."

 

The Company will announce its full year results for the year ended 31 December 2023 on Tuesday 9 April 2024. An analyst briefing will be given by Nigel Le Quesne, Chief Executive Officer, and Martin Fotheringham, Chief Financial Officer, at 09:30 BST via video / audio conference.

 

Enquiries:

JTC PLC +44 (0) 1534 700 000

Nigel Le Quesne, Chief Executive Officer

Martin Fotheringham, Chief Financial Officer

David Vieira, Chief Communications Officer

 

Camarco +44 (0) 20 3757 4985

Geoffrey Pelham-Lane

Sam Morris

 

About JTC

JTC is a publicly listed, global professional services business with deep expertise in fund, corporate and private client services. Every JTC person is an owner of the business and this fundamental part of our culture aligns us with the best interests of all of our stakeholders. Our purpose is to maximise potential and our success is built on service excellence, long-term relationships and technology capabilities that drive efficiency and add value. 

www.jtcgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAUWRSRUAOAR
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.